Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use technology utilizing light and its remittance to view suspicious moles and lesions up to two millimeters (mm) beneath in a pain-free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Comment by Insightful1on Jan 31, 2021 2:44am
135 Views
Post# 32430566

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Were Rolling..

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Were Rolling..Well let's hope you or a loved one never gets an aggresive cancer. I am sure you wouldn't reject any immunotherapy that could save your life. My wife is alive today because of the money that has been spent on cancer research. The statistics show a steep decline in cancer deaths since 1990 because of the R&D;

https://www.houstonchronicle.com/lifestyle/renew-houston/health/article/Cancer-death-rate-declines-sharply-partly-thanks-14960731.php

Cancer is a disease related to cell growth, it is extremely complex and comes in many forms. The key is to catch it early through screening thus giving the patient much better outcomes (that is MedX's technology) or  having a cancer that a immunotherapy or more advanced treatment  will cause to go into remision.

Investors have continued to invest in MedX and contrary to some posters here, MedX has attracted institutional investors;

https://btglobal.ca/blog/market-insights/we-invite-you-to-read-paul-beatties-feature-in-moneytalks-inside-edge-about-bt-globals-perspective-for-the-summer/

Recently, the increase in volume has occurred as MedX has been out speaking at investor conferences. I suspect that has brought some fresh eyes to the story. Unfortunately, medical investments can take a long time to unfold but MedX has recently shown a number of countries and clinic sales starting to produce revenue and I expect this trend to accelerate in 2021.GLTA
<< Previous
Bullboard Posts
Next >>